Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy

James J. Peterson; Roger H. Pak; Claude F. Meares

doi:10.1021/bc980118t

Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy

James J. Peterson, Roger H. Pak, Claude F. Meares

Chemistry

Research output: Contribution to journal › Article

43 Scopus citations

Abstract

A convenient approach to the functionalization of peptides with the macrocyclic 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) moiety has been developed. Protected components (using tert-butyl or tert-butyloxycarbonyl groups) of both the peptide and the chelate were assembled on the same solid resin support. Deprotection and cleavage of the resin-bound DOTA-peptides were performed in one step using a trifluoroacetic acid cleavage mixture to yield free DOTA-peptide amides.

Original language	English (US)
Pages (from-to)	316-320
Number of pages	5
Journal	Bioconjugate Chemistry
Volume	10
Issue number	2
DOIs	https://doi.org/10.1021/bc980118t
State	Published - Mar 1999

Fingerprint

ASJC Scopus subject areas

Chemistry(all)
Organic Chemistry
Clinical Biochemistry
Biochemistry, Genetics and Molecular Biology(all)
Biochemistry

Cite this

Peterson, J. J., Pak, R. H., & Meares, C. F. (1999). Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy. Bioconjugate Chemistry, 10(2), 316-320. https://doi.org/10.1021/bc980118t

@article{b3613cf9fa3743d1adf019ae2ad95db3,

title = "Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy",

abstract = "A convenient approach to the functionalization of peptides with the macrocyclic 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) moiety has been developed. Protected components (using tert-butyl or tert-butyloxycarbonyl groups) of both the peptide and the chelate were assembled on the same solid resin support. Deprotection and cleavage of the resin-bound DOTA-peptides were performed in one step using a trifluoroacetic acid cleavage mixture to yield free DOTA-peptide amides.",

author = "Peterson, {James J.} and Pak, {Roger H.} and Meares, {Claude F.}",

year = "1999",

month = mar

doi = "10.1021/bc980118t",

language = "English (US)",

volume = "10",

pages = "316--320",

journal = "Bioconjugate Chemistry",

issn = "1043-1802",

publisher = "American Chemical Society",

number = "2",

}

TY - JOUR

T1 - Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy

AU - Peterson, James J.

AU - Pak, Roger H.

AU - Meares, Claude F.

PY - 1999/3

Y1 - 1999/3

N2 - A convenient approach to the functionalization of peptides with the macrocyclic 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) moiety has been developed. Protected components (using tert-butyl or tert-butyloxycarbonyl groups) of both the peptide and the chelate were assembled on the same solid resin support. Deprotection and cleavage of the resin-bound DOTA-peptides were performed in one step using a trifluoroacetic acid cleavage mixture to yield free DOTA-peptide amides.

AB - A convenient approach to the functionalization of peptides with the macrocyclic 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) moiety has been developed. Protected components (using tert-butyl or tert-butyloxycarbonyl groups) of both the peptide and the chelate were assembled on the same solid resin support. Deprotection and cleavage of the resin-bound DOTA-peptides were performed in one step using a trifluoroacetic acid cleavage mixture to yield free DOTA-peptide amides.

UR - http://www.scopus.com/inward/record.url?scp=0033104341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033104341&partnerID=8YFLogxK

U2 - 10.1021/bc980118t

DO - 10.1021/bc980118t

M3 - Article

C2 - 10077483

AN - SCOPUS:0033104341

VL - 10

SP - 316

EP - 320

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 2

ER -

Access to Document

10.1021/bc980118t